What was Helix BioMedix’s price range in the past 12 months?
Helix BioMedix lowest stock price was $1.00 and its highest was $6.50 in the past 12 months.
What is Helix BioMedix’s market cap?
Helix BioMedix’s market cap is $739.29K.
When is Helix BioMedix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Helix BioMedix overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Helix BioMedix pay dividends?
Helix BioMedix does not currently pay dividends.
What is Helix BioMedix’s EPS estimate?
Helix BioMedix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Helix BioMedix have?
Helix BioMedix has 224,708 shares outstanding.
Which hedge fund is a major shareholder of Helix BioMedix?
Currently, no hedge funds are holding shares in HXBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Helix BioMedix
Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.